Differential gene expression and network analysis in head and neck squamous cell carcinoma

Area of Science:

• Genomics
• Oncology
• Biomarker Discovery

Background:

• Head and neck squamous cell carcinoma (HNSCC) is a common cancer with a poor prognosis.
• Detailed biomarker studies for HNSCC are limited.
• Genomic alterations and gene expression patterns in HNSCC require further investigation.

Purpose of the Study:

• To identify potential biomarkers for head and neck squamous cell carcinoma (HNSCC).
• To analyze gene expression patterns and protein-protein interactions in HNSCC.
• To explore the link between gene alterations and patient survival.

Main Methods:

• Collected and analyzed genomic data from HNSCC patients via The Cancer Genome Atlas (TCGA).
• Identified 793 differentially expressed genes (DEGs) and performed enrichment analysis.
• Constructed a protein-protein interaction network and selected 10 hub genes based on Maximal Clique Centrality score.

Main Results:

• Ten hub genes (PRAME, MAGEC2, MAGEA12, LHX1, MAGEA3, CSAG1, MAGEA6, LCE6A, LCE2D, LCE2C) were identified as potential HNSCC biomarkers.
• Kaplan-Meier survival analysis indicated that alterations in these genes correlate with decreased overall survival in HNSCC patients.
• Genomic alterations and differential expression of these genes are linked to HNSCC patient outcomes.

Conclusions:

• The identified 10 genes show promise as novel biomarkers for head and neck squamous cell carcinoma.
• These genes could be valuable targets for early diagnosis and precision therapy in HNSCC.
• Further exploration of these genomic alterations may lead to improved therapeutic strategies for HNSCC.